<DOC>
	<DOCNO>NCT00458185</DOCNO>
	<brief_summary>This study ass efficacy etanercept treatment Ankylosing Spondylitis ( AS ) .</brief_summary>
	<brief_title>Study Evaluating Etanercept Patients With Ankylosing Spondylitis</brief_title>
	<detailed_description />
	<mesh_term>Spondylitis</mesh_term>
	<mesh_term>Spondylitis , Ankylosing</mesh_term>
	<mesh_term>Etanercept</mesh_term>
	<criteria>Diagnosis AS , define Modified New York Criteria Ankylosing Spondylitis , age 18 70 year age . BASDAI great equal 40 ( score scale 0 100 ) . Negative result serum human chorionic gonadotropin ( HCG ) pregnancy test take screen woman except surgically sterile least 1 year postmenopausal . Complete ankylosis ( fusion ) spine . Previous receipt etanercept , antibody TNFα , TNFα inhibitor . Use disease modify antirheumatic drug ( DMARDs ) hydroxychloroquine , sulphasalazine , methotrexate within 4 week baseline . Patients treated hydroxychloroquine , sulphasalazine , methotrexate may continue drug study dos must hold stable 4 week baseline examination duration study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>March 2008</verification_date>
</DOC>